Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Noboru Takata"'
Autor:
Noboru Takata, Kiyo-aki Ishii, Hiroaki Takayama, Mayumi Nagashimada, Kyoko Kamoshita, Takeo Tanaka, Akihiro Kikuchi, Yumie Takeshita, Yukako Matsumoto, Tsuguhito Ota, Yasuhiko Yamamoto, Satoshi Yamagoe, Akihiro Seki, Yoshio Sakai, Shuichi Kaneko, Toshinari Takamura
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract It remains unclear how hepatic steatosis links to inflammation. Leukocyte cell-derived chemotaxin 2 (LECT2) is a hepatokine that senses fat in the liver and is upregulated prior to weight gain. The aim of this study was to investigate the si
Externí odkaz:
https://doaj.org/article/e247c50a13e443be9ca0d4e1e98cbdad
Autor:
Masaki Miyazawa, Masahiro Yanagi, Tomoyoshi Chiba, Hidenori Kido, Toshiki Matsuo, Masaki Nishitani, Noriaki Orita, Noboru Takata, Tomoyuki Hayashi, Akihiro Seki, Hidetoshi Nakagawa, Kouki Nio, Takeshi Terashima, Noriho Iida, Shinya Yamada, Hajime Takatori, Tetsuro Shimakami, Kuniaki Arai, Tatsuya Yamashita, Eishiro Mizukoshi
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 11, p1563-1568, 6p
Autor:
Yumie Takeshita, Masao Honda, Kenichi Harada, Yuki Kita, Noboru Takata, Hiromasa Tsujiguchi, Takeo Tanaka, Hisanori Goto, Yujiro Nakano, Noriho Iida, Kuniaki Arai, Tatsuya Yamashita, Eishiro Mizukoshi, Hiroyuki Nakamura, Shuichi Kaneko, Toshinari Takamura
Publikováno v:
Diabetes Care. 45:2064-2075
OBJECTIVE Nonalcoholic fatty liver disease (NAFLD) is a liver phenotype of type 2 diabetes and obesity. Currently, the efficacy of sodium–glucose cotransporter 2 (SGLT2) inhibitors and sulfonylureas in liver pathology and hepatic gene expression pr
Autor:
Toshinari Takamura, Shuichi Kaneko, Hiroyuki Nakamura, Eishiro Mizukoshi, Tatsuya Yamashita, Kuniaki Arai, Noriho Iida, Yujiro Nakano, Hisanori Goto, Takeo Tanaka, Hiromasa Tsujiguchi, Noboru Takata, Yuki Kita, Kenichi Harada, Masao Honda, Yumie Takeshita
OBJECTIVE Nonalcoholic fatty liver disease (NAFLD) is a liver phenotype of type 2 diabetes and obesity. Currently, the efficacy of sodium-glucose cotransporter 2 (SGLT2) inhibitors and sulfonylureas in liver pathology and hepatic gene expression prof
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c204f799310ca5f849176c48ac2f17f
https://doi.org/10.2337/figshare.20068982
https://doi.org/10.2337/figshare.20068982
Autor:
Toshinari Takamura, Yumie Takeshita, Yoshio Sakai, Kiyo-aki Ishii, Akihiro Kikuchi, Yukako Matsumoto, Kyoko Kamoshita, Satoshi Yamagoe, Mayumi Nagashimada, Shuichi Kaneko, Tsuguhito Ota, Noboru Takata, Yasuhiko Yamamoto, Akihiro Seki, Hiroaki Takayama, Takeo Tanaka
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports
Scientific Reports
It remains unclear how hepatic steatosis links to inflammation. Leukocyte cell-derived chemotaxin 2 (LECT2) is a hepatokine that senses fat in the liver and is upregulated prior to weight gain. The aim of this study was to investigate the significanc
Autor:
Hiroshi Sawayama, Hideo Baba, Yoshihiro Komohara, Hiroki Hirao, Ichirou Yoshinaka, Kazunori Harada, Noboru Takata, Kazuya Sakata
Publikováno v:
Clinical Journal of Gastroenterology. 13:759-765
Gastric neuroendocrine carcinoma (NEC) is an aggressive disease with high metastatic ability. Gastric cancer has intra-tumoral and intra-patient heterogeneity and may contain NEC. We discuss the case of a 75-year-old man who underwent distal gastrect
Autor:
Aya Sugiyama, Hidekuni Hidaka, Yoshiko Okikawa, Masahiro Yamamoto, Akira Kokubunji, Masazumi Okajima, Teruhisa Fujii, Junko Tanaka, Fumie Sasaki, Noboru Takata, Koji Iwato, Kazuyoshi Sato
Publikováno v:
Journal of Blood Medicine
Aya Sugiyama,1 Teruhisa Fujii,2,3 Yoshiko Okikawa,4 Fumie Sasaki,5 Masazumi Okajima,3,6 Hidekuni Hidaka,3,7 Koji Iwato,3,8 Kazuyoshi Sato,3,9 Akira Kokubunji,3,10 Noboru Takata,3,11 Masahiro Yamamoto,3,12 Junko Tanaka1,3 1Department of Epidemiology,
Autor:
Hisanori Goto, Yujiro Nakano, Eishiro Mizukoshi, Toshinari Takamura, Hiromasa Tsujiguchi, Takeo Tanaka, Noriho Iida, Masao Honda, Kenichi Harada, Shuichi Kaneko, Noboru Takata, Tatsuya Yamashita, Hiroyuki Nakamura, Yumie Takeshita, Kuniaki Arai, Yuki Kita
Publikováno v:
SSRN Electronic Journal.
Background: Nonalcoholic fatty liver disease (NAFLD) is a liver phenotype of type 2 diabetes and obesity. Currently, the efficacy of sodium-glucose cotransporter 2 (SGLT2) inhibitors and sulfonylureas in liver pathology and hepatic gene expression pr
Autor:
Yasuhito Takeda, Kazunori Kawaguchi, Taro Yamashita, Tatsuya Yamashita, Kuniaki Arai, Takeshi Terashima, Shuichi Kaneko, Noriho Iida, Hidenori Kido, Noboru Takata, Tetsuro Shimakami, Kazuya Kitamura, Eishiro Mizukoshi, Hajime Takatori, Masao Honda, Yoshio Sakai, Masaaki Kitahara
Publikováno v:
Hepatology research : the official journal of the Japan Society of HepatologyReferences. 51(2)
Aim Sequential administration of sorafenib followed by regorafenib or lenvatinib is effective against advanced hepatocellular carcinoma (HCC). In this study, we compared the safety profiles and anti-tumor effects of sequential sorafenib and regorafen
Autor:
Eiichiro Toyama, Masaaki Iwatsuki, Yuki Sakamoto, Kazunori Harada, Noboru Takata, Kazuya Sakata, Ichiro Yoshinaka, Hideo Baba
Publikováno v:
Surgery Today. 48:1031-1034
As a surgical treatment for a perforated duodenal ulcer, duodenal omental filling is effective. However, filling the perforation site with a sufficient amount of omentum is difficult in some situations. We herein report that we successfully filled a